可溶性AMH受体2作为女性生育障碍诊断标志物的研究
该回顾性横断面研究纳入186名患有不同妇科内分泌疾病的女性,分析可溶性抗苗勒管激素受体2(sAMHR2)与性激素的相关性及其诊断价值。结果显示sAMHR2与LH(r=0.898)和FSH(r=0.846)强相关;sAMHR2/AMH比值在诊断绝经后状态时AUC为0.997,cut-off为68.85时灵敏度和特异度分别为100%和98.2%。结论认为sAMHR2/AMH比值可能作为识别绝经后女性的有用生物标志物。
要点
- sAMHR2与LH(r=0.898)和FSH(r=0.846)强相关。
- PCOS诊断中AMH的AUC为0.981,cut-off 4 ng/ml,灵敏度96%,特异度94%。
- sAMHR2/AMH比值诊断绝经后状态AUC 0.997,cut-off 68.85,灵敏度100%,特异度98.2%。
核心结论
- sAMHR2/AMH比值可能作为识别绝经后女性的有用生物标志物用于不育诊断。
研究设计与样本
- 回顾性横断面研究,纳入186名患有不同妇科内分泌疾病的女性,采用混合效应模型分析sAMHR2与常规诊断性激素检测的相关性,并采用ROC曲线分析评估诊断性能。
主要发现
- sAMHR2与LH强相关(r=0.898),与FSH强相关(r=0.846);AMH与睾酮中度相关(r=0.666),与雄烯二酮中度相关(r=0.696)(所有P<0.001)。
- 诊断PCOS时,AMH表现最佳(AUC 0.981,cut-off 4 ng/ml),灵敏度96%,特异度94%。
- 卵巢功能不全女性的sAMHR2浓度和sAMHR2/AMH比值高于所有其他研究组,包括接受激素替代治疗的绝经后女性。
- 诊断绝经后状态时,sAMHR2/AMH比值(cut-off 68.85)的灵敏度和特异度最高,分别为100%和98.2%。
- sAMHR2/AMH比值(AUC 0.997)的诊断性能优于sAMHR2(AUC 0.947)、FSH(AUC 0.989)和LH(AUC 0.967)。
关键数值与推荐
- PCOS诊断:AMH cut-off 4 ng/ml,AUC 0.981,灵敏度96%,特异度94%。
- 绝经后状态诊断:sAMHR2/AMH比值cut-off 68.85,AUC 0.997,灵敏度100%,特异度98.2%。
临床怎么用
- sAMHR2/AMH比值可能用于不育诊断中识别绝经后女性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: The ectodomain of the anti-Müllerian hormone (AMH) type 2 receptor is shed by proteases under certain conditions, which makes it measurable in the blood. The aim of this study was to identify correlations of soluble anti-Müllerian hormone receptor type 2 (sAMHR2) with other sex hormone concentrations and to assess whether sAMHR2 may serve as a new biomarker in fertility disorders. DESIGN: In a retrospective cross-sectional study of women (n = 186) with different gynaecological-endocrinological disorders, mixed-effect models were used to analyse the correlation with established diagnostic hormone tests. Receiver operating characteristic curve analysis was performed to assess the diagnostic performance. RESULTS: There was a strong correlation of sAMHR2 with LH (r = 0.898) and FSH (r = 0.846) and a moderate correlation of AMH with testosterone (r = 0.666) and androstenedione (r = 0.696) (all P < 0.001). In diagnoses of polycystic ovary syndrome (PCOS), AMH showed the best performance (area under the curve [AUC] 0.981, cut-off 4 ng/ml) with 96% sensitivity and 94% specificity. sAMHR2 concentrations and sAMHR2/AMH ratios were elevated in women with ovarian insufficiency, compared with all other study groups, including post-menopausal women on hormone replacement therapy. Highest sensitivity and specificity (100% and 98.2%, respectively) were achieved with sAMHR2/AMH ratio for the diagnosis of post-menopausal status (cut-off 68.85). The sAMHR2/AMH ratio (AUC 0.997) had a better performance than sAMHR2 (AUC 0.947), FSH (AUC 0.989) and LH (AUC 0.967). CONCLUSIONS: The sAMHR2/AMH ratio may serve as a useful biomarker for infertility diagnostics to identify post-menopausal women.
引用
- Olivier LS, Evliyaoglu O, Weiskirchen R, et al. Investigation of soluble anti-Müllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders. Reprod Biomed Online. 2019. PMID: 31727499. doi:10.1016/j.rbmo.2019.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。